Literature DB >> 20159518

Current concepts in the surgical management of pancreatic cancer.

Ryan M Thomas1, Syed A Ahmad.   

Abstract

Pancreatic ductal adenocarcinoma (PDA) is the most common pancreatic malignancy comprising approximately 85% of cases. Many aspects of surgical resection of pancreatic cancer have been evaluated as to their effects on morbidity and mortality, including evaluation of anastomotic techniques, the role of extended lymphadenectomies, and the use of vascular reconstruction. Progress in the perioperative care of those undergoing pancreatic resection for PDA has resulted in improved outcomes. This review discusses the preoperative evaluation of a patient with pancreatic cancer and addresses the surgical management of these patients, with special attention to recent areas of progress and controversy.

Entities:  

Mesh:

Year:  2010        PMID: 20159518     DOI: 10.1016/j.soc.2009.11.001

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  4 in total

1.  Current surgical management of pancreatic cancer.

Authors:  Charles B Kim; Shuja Ahmed; Eddy C Hsueh
Journal:  J Gastrointest Oncol       Date:  2011-09

2.  Can pancreaticoduodenectomy performed at a comprehensive community cancer center have comparable results as major tertiary center?

Authors:  Charles Cheng; David Duppler; Boguslawa Koczon Jaremko
Journal:  J Gastrointest Oncol       Date:  2011-09

Review 3.  Advances in systemic therapy for advanced pancreatobiliary malignancies.

Authors:  Thorvardur R Halfdanarson; Sigurdis Haraldsdottir; Mitesh J Borad
Journal:  F1000Res       Date:  2013-04-08

4.  Tissue tolerable plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo.

Authors:  Lars Ivo Partecke; Katja Evert; Jan Haugk; Friderike Doering; Lars Normann; Stephan Diedrich; Frank-Ulrich Weiss; Matthias Evert; Nils Olaf Huebner; Cristin Guenther; Claus Dieter Heidecke; Axel Kramer; René Bussiahn; Klaus-Dieter Weltmann; Onur Pati; Claudia Bender; Wolfram von Bernstorff
Journal:  BMC Cancer       Date:  2012-10-15       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.